TARE is a minimally invasive, image-guided procedure for treating liver tumors.
1. Minimally invasive: TARE uses a catheter to deliver treatment through blood vessels, avoiding surgery or incisions.
2. Targeted radiation delivery: Radioactive microspheres are directed specifically to tumors, minimizing radiation exposure to healthy tissue.
3. Reduced side effects: Targeted approach limits radiation to tumor cells, reducing damage to surrounding healthy tissues.
4. Improved tumor control: TARE effectively shrinks tumors, improving control over primary and metastatic liver cancers.
1. Fatigue.
2. Nausea and vomiting.
3. Abdominal pain.
TARE is a minimally invasive treatment that delivers targeted radiation to tumors, primarily for liver cancer, using radioactive microspheres.
A catheter is inserted into an artery, and radioactive microspheres are injected directly into the tumor’s blood supply to deliver targeted radiation.
Yes, TARE is generally safe with minimal side effects, though some patients may experience fatigue, pain, or mild nausea.
Tumor response is typically seen within 4 to 8 weeks, with significant shrinkage occurring over several months.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. Please consult with a qualified healthcare professional for any medical concerns or treatment decisions.
Contact for appointments for Scans and Therapies.
+91-9650057298
+91-9355258181
Sector 8, Faridabad, Haryana, India